31 related articles for article (PubMed ID: 35131083)
1. PAK1 and Therapy Resistance in Melanoma.
Kichina JV; Maslov A; Kandel ES
Cells; 2023 Sep; 12(19):. PubMed ID: 37830586
[TBL] [Abstract][Full Text] [Related]
2. Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases.
Benzekry S; Schlicke P; Mogenet A; Greillier L; Tomasini P; Simon E
Clin Exp Metastasis; 2024 Feb; 41(1):55-68. PubMed ID: 38117432
[TBL] [Abstract][Full Text] [Related]
3. STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous Melanoma.
Dzung A; Saltari A; Tiso N; Lyck R; Dummer R; Levesque MP
J Invest Dermatol; 2022 Apr; 142(4):1171-1182.e10. PubMed ID: 34757069
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.
Huang FJ; Steeg PS; Price JE; Chiu WT; Chou PC; Xie K; Sawaya R; Huang S
Cancer Res; 2008 Dec; 68(23):9634-42. PubMed ID: 19047140
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Wu ZS; Cheng XW; Wang XN; Song NJ
Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
[TBL] [Abstract][Full Text] [Related]
6. MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines.
Vultur A; Villanueva J; Krepler C; Rajan G; Chen Q; Xiao M; Li L; Gimotty PA; Wilson M; Hayden J; Keeney F; Nathanson KL; Herlyn M
Oncogene; 2014 Apr; 33(14):1850-61. PubMed ID: 23624919
[TBL] [Abstract][Full Text] [Related]
7. STK11 Loss: A Novel Mechanism for Melanoma Metastasis with Therapeutic Implications.
Azin M; Demehri S
J Invest Dermatol; 2022 Apr; 142(4):1007-1009. PubMed ID: 35131083
[TBL] [Abstract][Full Text] [Related]
8. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.
Momtaz S; Niaz K; Maqbool F; Abdollahi M; Rastrelli L; Nabavi SM
Biofactors; 2017 May; 43(3):347-370. PubMed ID: 27896891
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target.
Villares GJ; Zigler M; Bar-Eli M
Oncotarget; 2011; 2(1-2):8-17. PubMed ID: 21378407
[TBL] [Abstract][Full Text] [Related]
10. Emerging molecular targets in melanoma invasion and metastasis.
Orgaz JL; Sanz-Moreno V
Pigment Cell Melanoma Res; 2013 Jan; 26(1):39-57. PubMed ID: 23095214
[TBL] [Abstract][Full Text] [Related]
11. Targeting STAT3 affects melanoma on multiple fronts.
Kortylewski M; Jove R; Yu H
Cancer Metastasis Rev; 2005 Jun; 24(2):315-27. PubMed ID: 15986140
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
